can be easily assembled in the pulmonary laboratory of most hospitals, is easy to carry, and can be used in conjunction with most commercially available sphygmomanometers. Furthermore, the cost of the device is minimal.
DESCRIPTION OF THEDEVICE
The device consists of four parts (Fig 1) . The disposable mouthpiece (Inspiron No. 001200) fits into one end of a 6-inch corrugated tube (Hudson Corr-A-Tube II, No. 1410). The other end of this tube is coupled to a connector (BardParker oxygen hose connector No. 5002) via a 22 X 22-mm adapter (Bard-Parker No. 5095). This connector fits snugly onto the male hub of the rubber tubing of most commercially available sphygmomanometers. An 18-gauge needle may be inserted into the adapter to equalize the intraoral and intrabronchial pressures during the strain phase of Valsalva's maneuver.4 The patient in the supine or semirecumbent position blows into the mouthpiece and maintains the column of mercury in the sphygmomanometer at 40 mm for a period of ten seconds. This device is presently being studied in a series of patients. We have now used this prosthesis in six patients, with no surgical deaths and no complications. Follow-up x-ray films and arteriograms have shown no tendency for thrombosis or migration of the prosthesis.
The high surgical mortality in acute dissection of the aorta is primarily due to hemorrhage from attempts to suture friable edematous tissue. By utilizing a sutureless prosthesis, this complication is avoided. The prosthesis may be inserted with little difficulty and thus a short duration of cross-clamp ing of the aorta. We believe that this is a significant advance in the treatment of thoracic aneurysms, and we are preparing to submit a complete report on our work in the near future. 
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